TickerFacts.

Bio Essence Corp (BIOE): Net Income

Annual figures by period end, from SEC filings.

$896.2K
Year ended 2025-12-31
$1.52M
Trailing 12 months to 2026-06-30
2020-12-31: -$595.8K2021-12-31: -$647.6K2022-12-31: -$809.7K2023-12-31: -$971.9K2024-12-31: -$1.31M2025-12-31: $896.2K$896.2K
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$896.2Kn/m2026-03-27, From 2025-01-01
2024-12-31-$1.31Mn/m2026-03-27, From 2024-01-01
2023-12-31-$971.9Kn/m2025-03-28, From 2023-01-01
2022-12-31-$809.7Kn/m2024-04-15, From 2022-01-01
2021-12-31-$647.6Kn/m2023-03-30, From 2021-01-01
2020-12-31-$595.8Kn/a2022-03-31, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Bio Essence Corp (BIOE)2025-12-31$896.2Kn/m
Lipocine Inc. (LPCN)2025-12-31-$9.63Mn/m
Dianthus Therapeutics, Inc. (DNTH)2025-12-31-$162.34Mn/m
Korsana Biosciences, Inc. (KRSA)2025-12-31-$3.53Mn/m
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31-$40.95Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.46Mn/m
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$28.62Mn/m
Avenue Therapeutics, Inc. (ATXI)2025-12-31-$2.91Mn/m
Northwest Biotherapeutics Inc (NWBO)2025-12-31-$60.16Mn/m

Compare BIOE, LPCN, DNTH, KRSA side by side · Screen every company in Pharmaceutical Preparations ↗